Correction to: Nature https://doi.org/10.1038/s41586-018-0810-y, published online 19 December 2018.
In this Letter, owing to an error in the production process, the additional author support information was omitted from the Supplementary Information. The Supplementary Information of the original Letter has been corrected online.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hilf, N., Kuttruff-Coqui, S., Frenzel, K. et al. Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 566, E13 (2019). https://doi.org/10.1038/s41586-019-0959-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41586-019-0959-z
This article is cited by
-
Computational identification of cross-reactive TCR epitopes with ARDitox
Journal of Cancer Research and Clinical Oncology (2025)
-
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?
Current Treatment Options in Oncology (2024)
-
Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens
Nature Biotechnology (2023)
-
Nanoengineered targeting strategy for cancer immunotherapy
Acta Pharmacologica Sinica (2020)
